Today on DrugResearcher.com
 
Big pharma reaches to Summit for zebrafish safety screening

Another safety scare for Roche

Takeda sleeping drug takes 'Worst Product Award'

Thermo continues fishing in India

Peptide chatter encourages bacteria to commit suicide

 
   
Related Industry News
 
Bayer banishes high dose MS drug

Explosions at two pharma plants

Applied Biosystems and Celera return first quarter profits

Survey asks: what to do about counterfeit drugs?

 
 
World Courier

Drug discovery

Breaking News on Drug Discovery
Daily  Tuesday 30 October 2007 Forward to a colleague

Technical / White Paper

The human approach to drug discovery and developmeBenefits of integrating human tissue research in drug discovery

The benefits of integrating human tissue research into drug discovery and development programs are in the confidence that they provide in the selection of the NCEs most likely to succeed in the clinic, and doing this in the most financially efficient way... Click Here

Access Full Stories



Big pharma reaches to Summit for zebrafish safety screening
Summit (formerly Vastox) has signed a $450,000 (€312,000) deal with one of the world's top 5 pharma firms to enable it to use Summit's zebrafish-platform in its drug safety programme... Read


Another safety scare for Roche
In another safety concern over a long-approved drug, Roche has been forced to add new warnings to its anti-transplant rejection drug CellCept (mycophenolate mofetil (MMF)) amid the news that it is associated with... Read


Takeda sleeping drug takes 'Worst Product Award'
Japanese pharma firm Takeda beat off strong competition from the likes of Coca-Cola to take home the dubious honour of Consumer International's 'Worst Product' award thanks to its sleeping pill ad... Read


Thermo continues fishing in India
Thermo Fisher Scientific continues to fish for new opportunities in India and has begun setting up a new clinical services base in the country... Read


Peptide chatter encourages bacteria to commit suicide
Scientists have discovered a peptide that enables bacteria to chat to one another, and can induce them to commit suicide, opening the door to new antibiotics... Read


All News Headlines for:
October | September | August

Enjoy your work with Biohit pipettors!Product Brochure

Have you got problems with aching hands in your lab?

Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more..... Click Here

Related Industry News



Bayer banishes high dose MS drug
Bayer Schering Pharma this week announced that it has scrapped plans to introduce a double-dose version of its top-selling multiple sclerosis (MS) drug Betaferon (interferon beta-1b) by the end of the year following... Read


Explosions at two pharma plants
Two pharmaceutical companies have faced explosions at their plants in the last week, local media reported... Read


Applied Biosystems and Celera return first quarter profits
Applied Biosystems (ABI) saw 5 per cent revenue growth during its first quarter of fiscal 2008 as sister company Celera posted revenue growth of 57 per cent... Read


Survey asks: what to do about counterfeit drugs?
Action should be taken to curb the counterfeit drug trade, but not via legal intervention, the results of a European survey say... Read

Weekly Comment

Pfizer partners in shock after surprise Exubera exit

We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find out the product was being scrapped through a press release. Read



Previous Headlines



Gene therapy offers protection from terrorist attack
A gene therapy has shown it could protect vital organs from the damaging effects of ionising radiation during a terrorist attack... Read


'Legendary' DNA Nobel Prize winner dies
Dr Arthur Kornberg, winner of the 1959 Nobel Prize for his work on how DNA is built, has died from respiratory failure at the age of 89... Read


Big pharma lends a helping hand
Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis... Read


Sulphur analysis speeds up protein quantification
Chinese researchers have developed a way to quickly quantify protein abundance using a mass spectrometry technique (MS) commonly used for elemental analysis... Read


GSK to strip down through outsourcing and offshoring
GlaxoSmithKline (GSK) is planning to strip itself down closer to the bare bones of the business through further outsourcing and offshoring, with hopes of making itself into a lean, mean, pharma machine... Read

Technical / White Papers, Case studies, Web casts
Benefits of integrating human tissue research in drug discovery - Technical / White Paper

Manufacturing Variations in Polysorbate Batches - Technical / White Paper



Product Information - brochures, Web centers
DAICEL chiral chromatography products - Company Profile

Rapid HPLC method development with ChromSword®Auto software - Product Presentation

Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com